PreciThera is a biotechnology company committed to the development of therapies for rare bone diseases using the combined application of computational technology and a deep understanding of disease pathology. The Company focuses on heterogeneous genetic disorders that primarily manifest in bone dysfunction. In depth understanding of disease mechanism will allow PreciThera’s targeted strategies to meaningfully impact both the skeletal symptoms as well as the extraskeletal issues found in these patients.

Montréal, CA
Size (employees)
4 (est)
PreciThera was founded in 2016 and is headquartered in Montréal, CA
Report incorrect company information

Key People/Management at PreciThera

Pierre Beauparlant

Pierre Beauparlant


PreciThera Office Locations

PreciThera has an office in Montréal
Montréal, CA (HQ)
408 1010 Rue Sherbrooke Ouest
Show all (1)
Report incorrect company information

PreciThera Financials and Metrics

Summary Metrics

Founding Date


Total Funding

$28.7 m

Latest funding size

$28.74 m

Time since last funding

10 months ago


PreciThera's latest funding round in July 2017 was reported to be $28.7 m. In total, PreciThera has raised $28.7 m
Show all financial metrics
Report incorrect company information